Skip to main content
. 2017 Oct;22(4):320–324. doi: 10.17712/nsj.2017.4.20170185

Table 2.

Outcome measures amongst eGFR groups.

Outcomes Estimated GFR (eGFR) levels p-value Adjusted OR OR, 95% C. I. (Lower – Upper)
>60 mL/min/1.73 m2 (n=596) ≤ 60 mL/min/1.73 m2 (n=131)
Death 17 (2.9) 14 (10.7) 0.002 3.772 (1.609 – 8.844)
Composite outcome 147 (24.7) 56 (42.7) 0.009 1.781 (1.153 – 2.751)
In hospital complications
 Pneumonia 37 (6.2) 8 (6.1) 0.733 0.866 (0.380 – 1.976)
 UTI 30 (5.0) 17 (13.0) 0.043 2.047 (1.024 – 4.093)
 VTE (DVT/PE) 12 (2.0) 1 (0.8) 0.224 0.267 (0.032– 2.243)
 Fall 15 (2.5) 1 (0.8) 0.220 0.276 (0.035 – 2.158)
 Bedsore 4 (0.7) 5 (3.8) 0.097 3.466 (0.800 – 15.010)
 Recurrence of stroke/ TIA 59 (9.9) 22 (16.8) 0.180 1.476 (0.835 – 2.609)
 Neurological deterioration 38 (6.4) 14 (10.7) 0.243 1.514 (0.755 – 3.038)
mRS disability category post-stroke at discharge
 Mildly disabled (0-2) 406 (72.6) 71 (61.7) 0.010
 Moderately to severely disabled (3-6) 153 (27.4) 44 (38.3)
 NIHSS value at discharge, mean±SD 4.18±7.567 7.14±11.882 0.011
NIHSS severity category at discharge
 Mild stroke (≤ 5) 448 (80.1) 83 (72.2) 0.011
 Moderate stroke (6 - 14) 63 (11.3) 18 (15.7)
 Severe stroke (>14) 48 (8.6) 14 (12.2)

eGFR - estimated glomerular filtration rate, UTI - urinary track infection, VTE - venous thromboembolism, DVT - deep venous thrombosis, PE - pulmonary embolism, TIA - transient ischemic attacks, mRS - modified Rankin Scale, NIHSS - National Institute of Health Stroke Score, Values are expressed as numbers and percentage n (%)